Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 386

1.

Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology.

D'Alto M, Romeo E, Argiento P, Sarubbi B, Santoro G, Grimaldi N, Correra A, Scognamiglio G, Russo MG, Calabrò R.

Int J Cardiol. 2012 Mar 22;155(3):378-82. doi: 10.1016/j.ijcard.2010.10.051. Epub 2010 Nov 16.

PMID:
21081251
[PubMed - indexed for MEDLINE]
2.

Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect.

D'Alto M, Vizza CD, Romeo E, Badagliacca R, Santoro G, Poscia R, Sarubbi B, Mancone M, Argiento P, Ferrante F, Russo MG, Fedele F, Calabrò R.

Heart. 2007 May;93(5):621-5. Epub 2006 Nov 29.

PMID:
17135220
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.

Garg N, Sharma MK, Sinha N.

Int J Cardiol. 2007 Sep 3;120(3):306-13. Epub 2006 Dec 15.

PMID:
17174417
[PubMed - indexed for MEDLINE]
4.

Comparative efficacy of sildenafil in Eisenmenger's syndrome secondary to atrial septal defect versus ventricular septal defect: a cardiac catheterisation follow-up study.

Garg N, Tripathy N, Sinha N.

Cardiol Young. 2011 Dec;21(6):631-8. doi: 10.1017/S1047951111000497. Epub 2011 Jun 8.

PMID:
21729508
[PubMed - indexed for MEDLINE]
5.

First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension.

Lunze K, Gilbert N, Mebus S, Miera O, Fehske W, Uhlemann F, Mühler EG, Ewert P, Lange PE, Berger F, Schulze-Neick I.

Eur J Clin Invest. 2006 Sep;36 Suppl 3:32-8.

PMID:
16919008
[PubMed - indexed for MEDLINE]
6.

Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study.

Zhang ZN, Jiang X, Zhang R, Li XL, Wu BX, Zhao QH, Wang Y, Dai LZ, Pan L, Gomberg-Maitland M, Jing ZC.

Heart. 2011 Nov;97(22):1876-81. doi: 10.1136/heartjnl-2011-300344. Epub 2011 Sep 21.

PMID:
21948962
[PubMed - indexed for MEDLINE]
7.

Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.

Mathai SC, Girgis RE, Fisher MR, Champion HC, Housten-Harris T, Zaiman A, Hassoun PM.

Eur Respir J. 2007 Mar;29(3):469-75. Epub 2006 Nov 1.

PMID:
17079256
[PubMed - indexed for MEDLINE]
Free Article
8.

Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.

McLaughlin VV, Benza RL, Rubin LJ, Channick RN, Voswinckel R, Tapson VF, Robbins IM, Olschewski H, Rubenfire M, Seeger W.

J Am Coll Cardiol. 2010 May 4;55(18):1915-22. doi: 10.1016/j.jacc.2010.01.027.

PMID:
20430262
[PubMed - indexed for MEDLINE]
Free Article
9.

Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.

Johnson RF, Loyd JE, Mullican AL, Fink CA, Robbins IM.

J Heart Lung Transplant. 2007 Apr;26(4):363-9. Epub 2007 Mar 2.

PMID:
17403478
[PubMed - indexed for MEDLINE]
10.

Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial.

Iversen K, Jensen AS, Jensen TV, Vejlstrup NG, Søndergaard L.

Eur Heart J. 2010 May;31(9):1124-31. doi: 10.1093/eurheartj/ehq011. Epub 2010 Mar 3.

PMID:
20202971
[PubMed - indexed for MEDLINE]
Free Article
11.

[Treatment with sildenafil, bosentan, or both in children and young people with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome].

Raposo-Sonnenfeld I, Otero-González I, Blanco-Aparicio M, Ferrer-Barba A, Medrano-López C.

Rev Esp Cardiol. 2007 Apr;60(4):366-72. Spanish.

PMID:
17521545
[PubMed - indexed for MEDLINE]
Free Article
12.

A retrospective study of bosentan in pulmonary arterial hypertension associated with congenital heart disease.

Durongpisitkul K, Jakrapanichakul D, Sompradikul S.

J Med Assoc Thai. 2008 Feb;91(2):196-202.

PMID:
18389984
[PubMed - indexed for MEDLINE]
13.

Effects of pulmonary vasodilator therapy on ventilatory efficiency during exercise in adults with Eisenmenger syndrome.

Yang-Ting S, Aboulhosn J, Sun XG, Child JS, Sietsema KE.

Congenit Heart Dis. 2011 Mar-Apr;6(2):139-46. doi: 10.1111/j.1747-0803.2011.00490.x. Epub 2011 Mar 21.

PMID:
21418531
[PubMed - indexed for MEDLINE]
14.

Long-term safety, tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease.

Diller GP, Dimopoulos K, Kaya MG, Harries C, Uebing A, Li W, Koltsida E, Gibbs JS, Gatzoulis MA.

Heart. 2007 Aug;93(8):974-6.

PMID:
17639112
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

[Preliminary study on the efficacy and safety of oral sildenafil in pulmonary arterial hypertension in China].

Xiong CM, He JG, Lu XL, Shan GL, Wu BX, Zhu XY, Wu GH, Zeng XF, Guo T, Liu ZH, Ni XH, Cheng XS, Gu Q, Zhao ZH, Tian HY, Li WM, Zhang DZ, Zhang C, Li MT, Liu HM, Guo YJ, Shen JY, Zhang WJ, Liu S, Zhou DX, Bao CD, Huang SA, Chen JY, Wu WF, Huang K, Li CL, Wang LH, He B.

Zhonghua Yi Xue Za Zhi. 2011 Feb 15;91(6):370-4. Chinese.

PMID:
21418907
[PubMed - indexed for MEDLINE]
16.

Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.

Launay D, Sitbon O, Le Pavec J, Savale L, Tchérakian C, Yaïci A, Achouh L, Parent F, Jais X, Simonneau G, Humbert M.

Rheumatology (Oxford). 2010 Mar;49(3):490-500. doi: 10.1093/rheumatology/kep398. Epub 2009 Dec 16.

PMID:
20015974
[PubMed - indexed for MEDLINE]
Free Article
17.

Pulmonary vasoreactivity predicts long-term outcome in patients with Eisenmenger syndrome receiving bosentan therapy.

D'Alto M, Romeo E, Argiento P, Santoro G, Sarubbi B, Gaio G, Mélot C, Russo MG, Naeije R, Calabrò R.

Heart. 2010 Sep;96(18):1475-9. doi: 10.1136/hrt.2010.199661. Epub 2010 Jul 28.

PMID:
20668108
[PubMed - indexed for MEDLINE]
18.

Therapy for pulmonary arterial hypertension due to congenital heart disease and Down's syndrome.

D'Alto M, Romeo E, Argiento P, D'Andrea A, Sarubbi B, Correra A, Scognamiglio G, Papa S, Bossone E, Calabrò R, Vizza CD, Russo MG.

Int J Cardiol. 2013 Apr 15;164(3):323-6. doi: 10.1016/j.ijcard.2011.07.009. Epub 2011 Jul 28.

PMID:
21802156
[PubMed - indexed for MEDLINE]
19.

Safety and tolerability of bosentan in adults with Eisenmenger physiology.

Gatzoulis MA, Rogers P, Li W, Harries C, Cramer D, Ward S, Mikhail GW, Gibbs JS.

Int J Cardiol. 2005 Jan;98(1):147-51.

PMID:
15676179
[PubMed - indexed for MEDLINE]
20.

Efficacy of bosentan in a small cohort of adult patients with pulmonary arterial hypertension related to congenital heart disease.

Benza RL, Rayburn BK, Tallaj JA, Coffey CS, Pinderski LJ, Pamoukian SV, Bourge RC.

Chest. 2006 Apr;129(4):1009-15.

PMID:
16608951
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk